Cargando...
Incorporating platelet glycoprotein iib/iiia inhibition in critical pathways: Unstable angina/non—st‐segment elevation myocardial infarction
Platelet glycoprotein (GP) IIb/IIIa inhibitors have been shown to be effective in reducing thrombotic events in patients with acute coronary syndromes undergoing percutaneous coronary intervention (PCI) and when used as medical therapy in patients with unstable angina/non‐ST‐segment elevation myocar...
Guardado en:
| Publicado en: | Clin Cardiol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wiley Periodicals, Inc.
2009
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656033/ https://ncbi.nlm.nih.gov/pubmed/10492851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960221606 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|